Poseida Therapeutics
(NASDAQ) PSTX
Poseida Therapeutics Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$150.86M
Net Income (TTM)
$59.40M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
PSTX News
PSTX: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Poseida Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
350
CEO
Kristin Yarema, PhD
Website
www.poseida.comHeadquarters
San Diego, CA 92121, US
PSTX Financials
Key Financial Metrics (TTM)
Gross Margin
-1%
Operating Margin
-2%
Net Income Margin
-2%
Return on Equity
-85%
Return on Capital
-64%
Return on Assets
-45%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$92.07M
Operating Income
$129.50M
EBITDA
$109.04M
Operating Cash Flow
$92.17M
Capital Expenditure
$3.07M
Free Cash Flow
$95.23M
Cash & ST Invst.
$212.20M
Total Debt
$85.42M
Poseida Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$71.75M
+667.2%
Gross Profit
$71.75M
+807.3%
Gross Margin
100.00%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
350
N/A
Net Income
$20.23M
+163.7%
EBITDA
$23.89M
+185.4%
Quarterly Fundamentals
Net Cash
$148.13M
-2.9%
Accounts Receivable
$14.75M
+70.1%
Inventory
$0.00
N/A
Long Term Debt
$76.64M
-25.0%
Short Term Debt
$6.08M
-48.5%
Return on Assets
-45.07%
N/A
Return on Invested Capital
-63.93%
N/A
Free Cash Flow
$10.24M
-244.2%
Operating Cash Flow
$9.59M
-221.6%